In 1980, Ludwig et al.[1] proposed the term “nonalcoholic steatohepatitis”(NASH) for a
histological condition resembling alcohol-related liver disease. This condition was observed …

The COVID-19 pandemic provides stark evidence of the importance of medicine on a global
scale. However, revisiting the influenza pandemic of 1918 provided a perspective as we …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem worldwide. To emphasize the close pathophysiological links between NAFLD and …

Nonalcoholic fatty liver disease (NAFLD), among the most common chronic liver diseases
worldwide, affects approximately 25% of the global population. Its incidence is increasing …

Despite great promise, developing and implementing machine learning (ML) models for
healthcare remains a challenging engineering task. The progression of disease generates …

Chronic kidney disease (CKD) and nonalcoholic fatty liver disease (NAFLD), metabolic
dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated …

This commentary is devoted to a recent study by Ren and Zheng (Nutr Metab Cardiovasc
Dis. 2023; 33: 1349-1357). These authors analyzed sex-stratified long-term outcomes …

Patients with metabolic syndrome are at a higher risk of nonalcoholic fatty liver disease
(NAFLD) and liver fibrosis than the general population. Still, accessibility of screening …

Abstract Introduction: Non-Alcoholic Fatty Liver Disease (NAFLD) is characterized by the
accumulation of fat in the liver and can progress to fibrosis and necroinflammatory changes …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide and is currently the second leading indication for liver transplantation. The global …